[{"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-001", "question": "A 68-year-old man with a history of severe aortic stenosis (mean gradient 48 mmHg, AVA 0.7 cm²) presents with decompensated heart failure. He is hypotensive (85/50 mmHg) and hypoxic despite high-flow oxygen. Transthoracic echocardiography shows a hyperdynamic left ventricle with near-cavity obliteration, severe mitral regurgitation (new, eccentric posteriorly directed jet), and systolic anterior motion of the mitral valve with LVOT obstruction (peak gradient 120 mmHg). Which of the following is the single most appropriate immediate pharmacologic intervention?", "options": ["Intravenous phenylephrine infusion", "Intravenous esmolol infusion", "Intravenous nitroglycerin infusion", "Intravenous furosemide bolus", "Intravenous milrinone infusion"], "answer": "A", "answer_index": 0, "explanation": "This patient has severe aortic stenosis with a dynamic LVOT obstruction (systolic anterior motion) precipitated by hypovolemia and hypercontractility, leading to hypotension and secondary mitral regurgitation. Phenylephrine, an alpha-agonist, increases afterload and blood pressure, which reduces the LVOT gradient and improves forward flow. Esmolol (negative inotrope) could worsen heart failure in the setting of severe AS. Nitroglycerin and furosemide reduce preload, exacerbating the obstruction. Milrinone is a positive inotrope and vasodilator, which would dramatically worsen the LVOT gradient and hypotension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient presents with severe aortic stenosis (AS), decompensated heart failure, hypotension, and significant LVOT obstruction due to systolic anterior motion (SAM) of the mitral valve. The LVOT obstruction, with a peak gradient of 120 mmHg, is a critical finding that exacerbates the hemodynamic compromise caused by the severe AS.\n\nThe management goals are to improve cardiac output, reduce the LVOT gradient, and avoid worsening the patient's already precarious hemodynamic state.\n\nLet's analyze the options:\nA. Intravenous phenylephrine infusion: Phenylephrine is a pure alpha-1 adrenergic agonist, increasing systemic vascular resistance (SVR). While increasing SVR could potentially reduce the LVOT gradient by increasing afterload and slowing LV emptying, it also significantly increases the impedance against which the stenotic aortic valve must eject blood. In severe AS, this increased afterload can lead to acute left ventricular failure, worsening myocardial oxygen demand and potentially precipitating a fatal outcome.\n\nB. Intravenous esmolol infusion: Esmolol is a beta-1 selective adrenergic blocker. In the context of SAM and LVOT obstruction, reducing myocardial contractility and heart rate is the cornerstone of management. Decreased contractility reduces the force pulling the mitral valve anteriorly, and a slower heart rate allows for increased diastolic filling time, which increases LV end-diastolic volume. Both effects reduce the LVOT gradient. While the patient is hypotensive, the hypotension is likely a consequence of the reduced effective forward cardiac output caused by the LVOT obstruction. Alleviating the obstruction is therefore paramount, and beta-blockers are the most direct pharmacologic approach to achieve this.\n\nC. Intravenous nitroglycerin infusion: Nitroglycerin is a vasodilator that reduces preload and afterload. Reducing preload would diminish LV end-diastolic volume, which can exacerbate LVOT obstruction and cavity obliteration, leading to further drops in blood pressure and cardiac output. Therefore, nitroglycerin is generally contraindicated in patients with LVOT obstruction.\n\nD. Intravenous furosemide bolus: Furosemide is a loop diuretic that reduces preload through diuresis. Similar to nitroglycerin, it can worsen LVOT obstruction by decreasing LV end-diastolic volume and is contraindicated in this scenario.\n\nE. Intravenous milrinone infusion: Milrinone is a phosphodiesterase-3 inhibitor with inotropic and vasodilatory effects. While it increases cardiac output, its vasodilatory effect can cause significant hypotension, which is already present. Furthermore, its inotropic effect might potentially worsen the SAM and LVOT obstruction, although this is debated. However, the risk of profound hypotension makes it a less desirable first-line choice compared to agents that directly address the obstruction.\n\nGiven the presence of severe AS and significant LVOT obstruction from SAM, the most appropriate immediate pharmacologic intervention is to reduce the LVOT gradient. Esmolol addresses this directly by reducing contractility and heart rate, which are key determinants of SAM and LVOT obstruction. While there is a risk of worsening hypotension, it is often necessary to manage the underlying obstructive process to improve forward flow and thus systemic perfusion.\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-002", "question": "A 3-day-old full-term neonate, born via uncomplicated vaginal delivery, is noted to have progressive tachypnea, grunting, and hypoxemia requiring 60% FiO2. Chest X-ray shows diffuse granular opacities with air bronchograms. Surfactant administration provides minimal improvement. Echocardiogram shows normal cardiac anatomy, but there is severe pulmonary hypertension with suprasystemic right ventricular pressures and right-to-left shunting across a patent foramen ovale. Which of the following underlying conditions is the most likely cause of this refractory pulmonary hypertension of the newborn?", "options": ["Congenital alveolar capillary dysplasia", "Meconium aspiration syndrome", "Transient tachypnea of the newborn", "Group B streptococcal pneumonia", "Idiopathic respiratory distress syndrome"], "answer": "A", "answer_index": 0, "explanation": "Congenital alveolar capillary dysplasia (ACD) with misalignment of pulmonary veins is a rare, lethal lung developmental disorder that presents identically to severe persistent pulmonary hypertension of the newborn (PPHN) but is completely refractory to all standard therapies, including surfactant, inhaled nitric oxide, and ECMO. The history of a full-term infant with rapid progression and lack of response to surfactant is classic. Meconium aspiration and sepsis can cause severe PPHN but typically show some response to aggressive management. Transient tachypnea and idiopathic RDS are not associated with such severe, immediate refractory pulmonary hypertension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient is a 3-day-old neonate presenting with severe respiratory distress, hypoxemia requiring high FiO2, and radiographic findings of diffuse granular opacities with air bronchograms. Crucially, the infant shows minimal improvement with surfactant administration, and echocardiography reveals severe pulmonary hypertension with suprasystemic right ventricular pressures and right-to-left shunting across a patent foramen ovale, despite normal cardiac anatomy. This constellation of findings strongly suggests Persistent Pulmonary Hypertension of the Newborn (PPHN) where the pulmonary hypertension is the primary or a very dominant issue, and it is refractory to standard treatments.\n\nLet's analyze the options:\nA. Congenital alveolar capillary dysplasia (ACD): This is a rare, severe congenital anomaly characterized by abnormal development of pulmonary arterioles and capillaries. It leads to intrinsic high pulmonary vascular resistance and severe, often refractory, pulmonary hypertension. Infants typically present with severe hypoxemia shortly after birth. The CXR can be variable but may show diffuse changes. The hallmark is severe, intractable pulmonary hypertension, which aligns perfectly with the echocardiographic findings and the poor response to surfactant.\n\nB. Meconium aspiration syndrome (MAS): MAS can cause respiratory distress, hypoxemia, and pulmonary hypertension secondary to hypoxic lung injury and meconium-induced inflammation. While PPHN can occur, the CXR findings of diffuse granular opacities with air bronchograms are more classic for RDS, not typically the patchy or streaky opacities seen in MAS. Also, surfactant response is not the primary treatment for MAS itself. MAS is an underlying cause of lung injury that can lead to PPHN, but ACD is a primary vascular anomaly causing the PPHN.\n\nC. Transient tachypnea of the newborn (TTN): TTN is usually milder, occurs typically in infants born via C-section, and resolves within 24-72 hours. CXR findings are typically increased vascular markings or fluid in fissures. It does not typically cause severe, refractory pulmonary hypertension requiring high FiO2 on day 3.\n\nD. Group B streptococcal pneumonia (GBS pneumonia): GBS pneumonia is a severe bacterial infection that can cause diffuse infiltrates, hypoxemia, and secondary pulmonary hypertension. While it is a serious condition, the description \"refractory pulmonary hypertension of the newborn\" as the primary problem, with poor response to surfactant, points more towards a primary vascular issue. GBS pneumonia would be treated with antibiotics.\n\nE. Idiopathic respiratory distress syndrome (IRDS): IRDS (Hyaline Membrane Disease) is caused by surfactant deficiency, primarily affecting premature infants. The CXR findings (diffuse granular opacities with air bronchograms) are classic for IRDS. However, the key piece of information is that \"surfactant administration provides minimal improvement.\" In classic IRDS, surfactant is the definitive treatment and should lead to significant improvement. Its failure to do so, combined with severe, refractory pulmonary hypertension, suggests that IRDS is unlikely to be the primary underlying cause, or there is a superimposed severe process.\n\nConsidering the severe, refractory nature of the pulmonary hypertension with suprasystemic pressures and the lack of response to surfactant, congenital alveolar capillary dysplasia (ACD) is the most fitting diagnosis. ACD is a primary vascular anomaly that directly causes severe, intractable pulmonary hypertension. The lung parenchymal changes described can be a consequence of this severe PPHN.\n\nThe final answer is $\\boxed{A}$."}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-003", "question": "A 42-year-old woman is brought to the ED after a high-speed motor vehicle collision. Primary survey reveals a Glasgow Coma Scale of 14, heart rate 130 bpm, BP 88/50 mmHg, and SpO2 94% on room air. Focused Assessment with Sonography for Trauma (FAST) is positive for fluid in the hepatorenal recess. After initiating a massive transfusion protocol, her blood pressure transiently improves with crystalloid, then drops again. Bedside ultrasound now shows a new, large pericardial effusion with diastolic right ventricular collapse. Which of the following is the most appropriate immediate procedural intervention?", "options": ["Emergency department thoracotomy", "Pericardiocentesis via subxiphoid approach", "Left anterolateral tube thoracostomy", "Right tube thoracostomy", "Laparotomy with aortic cross-clamping"], "answer": "B", "answer_index": 1, "explanation": "The patient has developed cardiac tamponade (evidenced by diastolic RV collapse on ultrasound) in the context of trauma and a positive FAST exam, suggesting concurrent intra-abdominal hemorrhage. In blunt trauma, the cause is likely myocardial rupture or coronary vessel injury. Pericardiocentesis is the immediate life-saving procedure to relieve tamponade while simultaneously preparing for definitive operative management. ED thoracotomy is indicated for penetrating trauma with recent loss of signs of life. Tube thoracostomy addresses hemothorax, not pericardial tamponade. Laparotomy addresses the abdominal hemorrhage but would not relieve the cardiac tamponade, and the patient would likely arrest on induction of anesthesia.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient presents with signs of shock (hypotension, tachycardia) following a high-speed motor vehicle collision. Initial management involved a massive transfusion protocol, and the FAST scan suggested possible intra-abdominal bleeding. Despite resuscitation, her blood pressure dropped again. The critical new finding is a large pericardial effusion with diastolic right ventricular collapse, which is diagnostic of cardiac tamponade. Cardiac tamponade causes obstructive shock due to impaired filling of the ventricles. The most appropriate immediate procedural intervention for cardiac tamponade is pericardiocentesis to drain the effusion and relieve the pressure on the heart.\n\nLet's consider the other options:\nA. Emergency department thoracotomy is typically reserved for penetrating trauma with signs of life or severe blunt trauma where immediate open chest access is required to control massive hemorrhage or release tamponade when pericardiocentesis is not feasible or has failed. Given the explicit ultrasound finding of tamponade and its treatability with pericardiocentesis, thoracotomy is a more drastic measure.\nC and D. Tube thoracostomy is indicated for pneumothorax or hemothorax, which are not specifically identified as the primary cause of the current decompensation, although blunt chest trauma could cause these. However, the most critical emergent finding is tamponade.\nE. Laparotomy with aortic cross-clamping is indicated for severe intra-abdominal hemorrhage. While initial FAST was positive for fluid that could be blood, the immediate life-threatening condition identified is cardiac tamponade, which needs to be addressed first. If tamponade is relieved and the patient remains hypotensive, then the source of bleeding (e.g., intra-abdominal) would be re-evaluated.\n\nTherefore, pericardiocentesis is the most appropriate next step to manage the identified life-threatening cardiac tamponade.\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-004", "question": "A 28-year-old woman presents with a 6-month history of symmetric inflammatory polyarthritis affecting her wrists, MCPs, and knees, morning stiffness >1 hour, and a new facial rash. Labs show ANA 1:1280 (speckled), anti-dsDNA negative, anti-Smith positive, anti-RNP positive, complement levels normal, and urinalysis with 2+ protein but no cellular casts. She is started on hydroxychloroquine. Two weeks later, she develops acute dyspnea, pleuritic chest pain, and hypoxia. CT pulmonary angiography shows no pulmonary embolism but reveals extensive bilateral ground-glass opacities and pleural effusions. Which of the following is the most likely diagnosis?", "options": ["Lupus pneumonitis", "Drug reaction to hydroxychloroquine", "Acute pulmonary hemorrhage from vasculitis", "Pulmonary hypertension due to SLE", "Opportunistic infection due to immunosuppression"], "answer": "A", "answer_index": 0, "explanation": "The patient has SLE (meeting criteria with arthritis, malar rash, anti-Smith positivity). The acute respiratory presentation with ground-glass opacities and pleural effusions in this context is most consistent with acute lupus pneumonitis, a rare but severe manifestation of SLE. Timing makes drug reaction unlikely, as hydroxychloroquine toxicity is typically chronic and not acute pulmonary. Pulmonary hemorrhage would show falling hematocrit and more alveolar filling. Pulmonary hypertension is a chronic process. Opportunistic infection is improbable given the very short course of a minimally immunosuppressive agent (hydroxychloroquine).", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient presents with a history strongly suggestive of Systemic Lupus Erythematosus (SLE) or Mixed Connective Tissue Disease (MCTD) given the symmetric polyarthritis, morning stiffness, malar rash (implied by \"facial rash\" in the context of SLE), positive ANA, anti-Smith, and anti-RNP antibodies. While anti-dsDNA is negative, this does not exclude SLE.\n\nShe develops acute dyspnea, pleuritic chest pain, and hypoxia two weeks after starting hydroxychloroquine (HCQ). CT pulmonary angiography reveals no pulmonary embolism but shows bilateral ground-glass opacities and pleural effusions.\n\nLet's evaluate the options:\n\nA. Lupus pneumonitis: Lupus pneumonitis is a serious and potentially life-threatening complication of SLE. It can manifest acutely with symptoms such as dyspnea, cough, chest pain, and hypoxia. Radiographic findings often include diffuse infiltrates, ground-glass opacities, atelectasis, and pleural effusions. The patient's presentation with acute respiratory distress, hypoxia, ground-glass opacities, and pleural effusions, in the context of probable SLE, is highly consistent with lupus pneumonitis.\n\nB. Drug reaction to hydroxychloroquine: Hydroxychloroquine can cause pneumonotoxicity, but this is typically seen after prolonged therapy (months to years) and usually manifests as interstitial lung disease. Acute pulmonary toxicity from HCQ is uncommon and not the usual presentation of ground-glass opacities and pleural effusions.\n\nC. Acute pulmonary hemorrhage from vasculitis: Pulmonary hemorrhage is a recognized manifestation of SLE, often due to vasculitis affecting the pulmonary vasculature. The cardinal symptom is hemoptysis (coughing up blood), which is not mentioned in this case. While dyspnea, hypoxia, and diffuse infiltrates can be present, the absence of hemoptysis makes this diagnosis less likely than lupus pneumonitis. Imaging typically shows alveolar-filling patterns (hemorrhage) rather than predominantly ground-glass opacities.\n\nD. Pulmonary hypertension due to SLE: Pulmonary hypertension can occur in SLE, but it is usually a chronic complication, often characterized by progressive dyspnea and signs of right heart failure. Acute onset with diffuse ground-glass opacities and pleural effusions is not the typical presentation of pulmonary hypertension.\n\nE. Opportunistic infection due to immunosuppression: While the patient is on hydroxychloroquine, it is not a potent immunosuppressant, and she has only been on it for two weeks. The risk of opportunistic infections developing this acutely and with this specific imaging pattern (ground-glass opacities and pleural effusions are not the hallmark of common opportunistic infections like PCP) is relatively low compared to a direct SLE manifestation.\n\nConsidering the acute onset of respiratory symptoms, hypoxia, and the typical imaging findings of ground-glass opacities and pleural effusions in a patient with established criteria for SLE, lupus pneumonitis is the most likely diagnosis.\n\nThe final answer is $\\boxed{A}$."}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-005", "question": "A 55-year-old man with a history of MEN1 syndrome (previous parathyroidectomy, pancreatic neuroendocrine tumor resection) presents with profound hypoglycemia (glucose 38 mg/dL) and inappropriately elevated serum insulin and C-peptide during a supervised fast. Localizing studies, including endoscopic ultrasound and Ga-68 DOTATATE PET/CT, show no identifiable pancreatic lesion. Which of the following is the most appropriate next step in management?", "options": ["Empiric distal pancreatectomy", "Initiation of diazoxide therapy", "Selective arterial calcium stimulation with hepatic venous sampling", "Empiric total pancreatectomy", "Long-acting somatostatin analog therapy (e.g., lanreotide)"], "answer": "C", "answer_index": 2, "explanation": "In a patient with MEN1 and biochemically proven endogenous hyperinsulinemic hypoglycemia (insulinoma) with negative conventional and advanced imaging, the next step is selective arterial calcium stimulation (SACS) with hepatic venous sampling. This invasive angiographic procedure can regionalize the source of insulin secretion to a specific pancreatic arterial territory (gastroduodenal, superior mesenteric, or splenic arteries), guiding targeted surgical exploration. Empiric distal or total pancreatectomy carries high morbidity and may miss the lesion. Diazoxide and somatostatin analogs are temporizing medical therapies but do not address the need for definitive localization and resection in a surgical candidate.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient presents with symptomatic hypoglycemia and biochemical evidence of endogenous hyperinsulinism (elevated insulin and C-peptide during fasting). The history of MEN1 syndrome, previous parathyroidectomy, and pancreatic neuroendocrine tumor (PNET) resection raises the suspicion for a recurrent or new insulinoma. However, advanced localizing studies, including endoscopic ultrasound and Ga-68 DOTATATE PET/CT, have failed to identify a pancreatic lesion.\n\nIn cases of hyperinsulinism where non-invasive imaging is negative but clinical suspicion remains high for a localized lesion, selective arterial calcium stimulation with hepatic venous sampling (SACSHVS) is the gold standard diagnostic procedure to localize the source of insulin hypersecretion. This invasive technique helps pinpoint the location of insulinomas by stimulating insulin release with calcium infusion into specific arteries and measuring insulin gradients in hepatic venous blood.\n\nLet's consider the other options:\nA. Empiric distal pancreatectomy: Performing surgery without a localized lesion is not appropriate and could lead to unnecessary morbidity.\nB. Initiation of diazoxide therapy: Diazoxide is a medical management option for hyperinsulinism, particularly when the cause is unresectable or diffuse. However, it is typically initiated after localization efforts have been exhausted, or if an early diagnosis of unresectable disease is made (e.g., diffuse nesidioblastosis). Given the high suspicion for a PNET in a MEN1 patient, further localization is warranted before committing solely to medical management.\nD. Empiric total pancreatectomy: This is a highly aggressive surgical intervention reserved for severe, diffuse, or unresectable hyperinsulinism refractory to other treatments, and it is not an appropriate empirical first step after negative imaging.\nE. Long-acting somatostatin analog therapy (e.g., lanreotide): While somatostatin analogs can inhibit hormone release from some PNETs, they are often less effective for controlling hyperinsulinism compared to diazoxide and are not the primary next step for localization or definitive management of an insulinoma.\n\nTherefore, SACSHVS is the most appropriate next diagnostic step to try and locate the source of hyperinsulinism before proceeding with further management decisions.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-006", "question": "A 7-year-old boy is evaluated for short stature. He has a history of congenital hypothyroidism diagnosed on newborn screening, treated with levothyroxine. Growth chart shows length and weight at the 5th percentile at birth, falling to below the 1st percentile by age 3. Current bone age is delayed by 3 years. Physical exam reveals a prominent forehead, depressed nasal bridge, and small hands with brachydactyly. Labs show normal TSH and free T4 on replacement. Which of the following genetic mutations is most likely responsible for this clinical picture?", "options": ["SHOX gene mutation", "GH1 gene mutation (isolated GH deficiency)", "GNAS1 gene mutation (Albright hereditary osteodystrophy)", "PROP1 gene mutation (combined pituitary hormone deficiency)", "FGFR3 gene mutation (achondroplasia)"], "answer": "D", "answer_index": 3, "explanation": "The combination of congenital hypothyroidism, severe postnatal growth failure with delayed bone age, and mild facial dysmorphism is classic for combined pituitary hormone deficiency (CPHD) due to a PROP1 mutation. PROP1 is a pituitary transcription factor critical for the development of somatotrophs, lactotrophs, thyrotrophs, and gonadotrophs. Deficiency presents with growth hormone, TSH, and later gonadotropin deficiencies. The congenital hypothyroidism was central (pituitary), not primary thyroidal. SHOX mutations cause Leri-Weill dyschondrosteosis. GNAS1 mutations cause pseudohypoparathyroidism with specific skeletal findings (brachydactyly type E). Isolated GH deficiency or achondroplasia would not explain the central hypothyroidism.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient presents with short stature, a history of congenital hypothyroidism treated with levothyroxine, a growth pattern falling from the 5th to below the 1st percentile, and a bone age delayed by 3 years. Physical exam reveals a prominent forehead, depressed nasal bridge, and small hands with brachydactyly.\n\nLet's analyze each option:\nA.  SHOX gene mutation: Mutations in the SHOX gene are associated with short stature and skeletal dysplasia, including short trunk, short limbs, and sometimes features seen in Turner syndrome. While brachydactyly and short stature are consistent, prominent forehead and depressed nasal bridge are not particularly hallmark features of SHOX deficiency alone. Congenital hypothyroidism is also not a direct consequence, though it can co-occur in complex conditions.\n\nB.  GH1 gene mutation (isolated GH deficiency): Isolated GH deficiency leads to GH deficiency, causing short stature and a delayed bone age. However, it typically results in proportional short stature and does not present with the specific dysmorphic facial features (prominent forehead, depressed nasal bridge) or brachydactyly described.\n\nC.  GNAS1 gene mutation (Albright hereditary osteodystrophy - AHO): Mutations in the GNAS1 gene cause Albright hereditary osteodystrophy (AHO) and its related conditions like pseudohypoparathyroidism (PHP). Key features of AHO include short stature, brachydactyly, obesity, and characteristic facial features such as a prominent forehead, depressed nasal bridge, and rounded face. Delayed bone age is also common due to associated hormonal dysfunction. While congenital hypothyroidism is not the primary defining feature, GNAS1 mutations affect G-protein signaling, which can lead to endocrine resistance or dysfunction in multiple axes, including the thyroid axis. Therefore, hypothyroidism (primary or secondary) can be associated with GNAS1 mutations. This option provides the strongest match for the constellation of physical and skeletal findings.\n\nD.  PROP1 gene mutation (combined pituitary hormone deficiency): PROP1 gene mutations are a common cause of combined pituitary hormone deficiency, leading to deficiencies in GH, TSH, ACTH, and gonadotropins. This explains short stature (GH deficiency), congenital central hypothyroidism (TSH deficiency), and delayed bone age. However, it does not explain the prominent forehead, depressed nasal bridge, or brachydactyly, which are not typical features of PROP1 deficiency.\n\nE.  FGFR3 gene mutation (achondroplasia): Activating mutations in FGFR3 cause achondroplasia, the most common form of disproportionate dwarfism. Achondroplasia presents with short limbs, macrocephaly, frontal bossing (prominent forehead), midface hypoplasia (depressed nasal bridge), and brachydactyly with trident-shaped hands. However, achondroplasia is characterized by disproportionate short stature, and bone age is typically normal or advanced, not delayed by 3 years. Furthermore, congenital hypothyroidism is not a recognized feature of achondroplasia.\n\nComparing the options, the combination of prominent forehead, depressed nasal bridge, and brachydactyly are highly characteristic of GNAS1 mutations leading to Albright's hereditary osteodystrophy. The short stature and delayed bone age are also consistent. While congenital hypothyroidism is not the primary hallmark, associated endocrine dysfunction is present in GNAS1-related disorders. Therefore, GNAS1 is the most likely genetic mutation responsible for this clinical picture.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-007", "question": "A 70-year-old man with severe, calcific aortic stenosis (AVA 0.6 cm², mean gradient 55 mmHg) and chronic kidney disease (eGFR 28 mL/min/1.73m²) presents with recurrent hospitalizations for heart failure with preserved ejection fraction (LVEF 65%). He is deemed high-risk for surgical AVR. He undergoes transcatheter aortic valve implantation (TAVI) with a balloon-expandable valve. Immediately post-deployment, transesophageal echocardiography shows a well-seated valve with mild paravalvular leak, mean gradient 8 mmHg, and new severe mitral regurgitation with a wide vena contracta and eccentric anteriorly directed jet. The left ventricular systolic function appears hyperdynamic. What is the most likely mechanism of the acute severe mitral regurgitation?", "options": ["Iatrogenic injury to the mitral valve apparatus from the delivery system", "Dynamic left ventricular outflow tract obstruction causing systolic anterior motion of the mitral valve", "Unmasking of pre-existing severe ischemic mitral regurgitation due to afterload reduction", "Valve prosthesis impingement on the anterior mitral leaflet", "Acute papillary muscle dysfunction due to coronary occlusion"], "answer": "B", "answer_index": 1, "explanation": "In a patient with severe AS and a small, hypertrophied, hyperdynamic left ventricle, relief of the afterload obstruction via TAVI can precipitate dynamic LVOT obstruction. This leads to systolic anterior motion (SAM) of the mitral valve, causing acute, severe mitral regurgitation with an eccentric anterior jet. This is a recognized complication of TAVI, particularly in patients with certain anatomical predictors (septal hypertrophy, small LV cavity). Direct injury from the delivery system is rare. Pre-existing severe MR would have been evident pre-procedure. Prosthetic impingement typically causes central MR. Coronary occlusion is possible but would more likely cause regional wall motion abnormalities and ischemic MR.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient presents with new-onset severe mitral regurgitation (MR) immediately after transcatheter aortic valve implantation (TAVI) for severe aortic stenosis. Key findings include a hyperdynamic left ventricle (LV) and an anteriorly directed MR jet.\n\nLet's analyze the options:\n\nA. Iatrogenic injury to the mitral valve apparatus from the delivery system: While possible, the description of a severe MR with a wide vena contracta and an anteriorly directed jet is particularly characteristic of another phenomenon. Direct injury might cause a different pattern of regurgitation.\n\nB. Dynamic left ventricular outflow tract obstruction causing systolic anterior motion of the mitral valve: Severe aortic stenosis often leads to concentric left ventricular hypertrophy, which, coupled with the subsequent relief of afterload and potentially a hyperdynamic LV following TAVI, can predispose to dynamic LVOT obstruction. In this condition, the anterior mitral leaflet is drawn anteriorly towards the hypertrophied interventricular septum during systole (systolic anterior motion, SAM). This abnormal motion prevents proper coaptation of the mitral leaflets, leading to severe MR. The MR jet in SAM is often anteriorly directed, originating from the area where the anterior leaflet is displaced. This aligns well with the observed severe MR with an anteriorly directed jet and a hyperdynamic LV.\n\nC. Unmasking of pre-existing severe ischemic mitral regurgitation due to afterload reduction: There is no mention of ischemic heart disease or prior myocardial infarction. Furthermore, ischemic MR typically results from papillary muscle dysfunction, which usually causes a posteromedially directed jet, not anteriorly.\n\nD. Valve prosthesis impingement on the anterior mitral leaflet: Although a TAVI prosthesis can potentially impinge on the mitral valve, especially if malpositioned, this is not as strong an explanation for an *anteriorly directed* severe MR jet as SAM. Prosthetic impingement might cause restricted movement or distortion, but the dynamic anterior displacement of the leaflet is the classic mechanism for SAM-induced MR.\n\nE. Acute papillary muscle dysfunction due to coronary occlusion: Similar to option C, there is no indication of acute ischemia or infarction. Also, papillary muscle dysfunction typically leads to MR directed towards the posterior part of the left atrium.\n\nGiven the findings of new severe MR with an anteriorly directed jet in a patient with a hyperdynamic LV post-TAVI, dynamic LVOT obstruction causing SAM is the most likely mechanism.\n\nThe answer is (B)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-008", "question": "A 4-week-old male infant is admitted with a 2-day history of poor feeding, lethargy, and vomiting. He was born at term, breastfeeding well until this illness. Vital signs: T 36.8°C, HR 180 bpm, RR 65/min, BP 65/40 mmHg, SpO2 98% room air. He is mottled, with delayed capillary refill. Laboratory studies show: Na 125 mEq/L, K 8.9 mEq/L, Cl 94 mEq/L, CO2 14 mEq/L, glucose 48 mg/dL, Ca 9.8 mg/dL. Point-of-care cortisol is 2 mcg/dL (drawn prior to any steroid administration). Which of the following is the most urgent diagnostic test to confirm the underlying etiology?", "options": ["Plasma renin activity and aldosterone level", "Karyotype analysis", "Serum 17-hydroxyprogesterone level", "ACTH stimulation test", "Urine organic acid analysis"], "answer": "C", "answer_index": 2, "explanation": "The infant presents in acute adrenal crisis with profound hyponatremia, hyperkalemia, hypoglycemia, and low cortisol, diagnostic of primary adrenal insufficiency. The most common cause in a male infant is congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, which is detected by a markedly elevated serum 17-hydroxyprogesterone level. This is the most urgent specific diagnostic test, as it guides definitive management and genetic counseling. Plasma renin activity will be elevated, but does not specify the etiology. Karyotype is not urgent; males with CAH have a 46,XY karyotype. An ACTH stimulation test is diagnostic for adrenal insufficiency but is contraindicated in acute crisis and does not identify the specific enzyme defect. Urine organic acids help diagnose other metabolic disorders.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient is a 4-week-old male infant presenting with symptoms and laboratory findings highly suggestive of an adrenal crisis, likely due to primary adrenal insufficiency. These symptoms include poor feeding, lethargy, vomiting, hypotension (BP 65/40 mmHg), tachycardia, mottled skin, delayed capillary refill, hyponatremia (Na 125 mEq/L), severe hyperkalemia (K 8.9 mEq/L), metabolic acidosis (CO2 14 mEq/L), hypoglycemia (glucose 48 mg/dL), and a low point-of-care cortisol level (2 mcg/dL).\n\nThe combination of hyponatremia and severe hyperkalemia in an infant with adrenal insufficiency strongly points to deficiency in both glucocorticoids and mineralocorticoids. Congenital adrenal hyperplasia (CAH) is a common cause of such presentation, particularly the salt-wasting form due to 21-hydroxylase deficiency, which is the most common enzymatic defect (90-95% of CAH cases). This deficiency leads to impaired synthesis of cortisol and aldosterone, resulting in accumulation of androgen precursors and precursor steroids like 17-hydroxyprogesterone.\n\nLet's analyze the given options to determine the most urgent diagnostic test to confirm the underlying etiology:\n\nA. Plasma renin activity and aldosterone level: Measuring these would help confirm mineralocorticoid deficiency but does not specifically identify the genetic cause of CAH as directly as other tests might. While high renin and low aldosterone are expected, it doesn't pinpoint 21-hydroxylase deficiency as the specific etiology.\n\nB. Karyotype analysis: This is indicated for chromosomal abnormalities, which are not the primary cause of the described symptoms and electrolyte imbalances in this context.\n\nC. Serum 17-hydroxyprogesterone level: This is a key marker for 21-hydroxylase deficiency CAH. A significantly elevated level confirms this specific, common, and treatable etiology of adrenal insufficiency in this age group, explaining the observed clinical and laboratory findings. This test is crucial for confirming the diagnosis of the most likely cause of the patient's crisis.\n\nD. ACTH stimulation test: This test is the gold standard for diagnosing adrenal insufficiency and determining whether it is primary (adrenal gland failure) or secondary/tertiary (pituitary/hypothalamic dysfunction). However, given the severe electrolyte abnormalities, particularly the profound hyperkalemia, and the low baseline cortisol, primary adrenal insufficiency is highly suspected, with CAH being the leading differential. In a critically ill infant, identifying the specific, common *etiology* like CAH might be prioritized over the general diagnosis of adrenal insufficiency via ACTH stimulation, if the suspicion for CAH is already very high. Measuring 17-hydroxyprogesterone directly addresses confirming the suspicion of CAH.\n\nE. Urine organic acid analysis: This test is used to diagnose inborn errors of metabolism like organic acidemias. While some metabolic disorders can present with similar symptoms, the specific pattern of hyponatremia, severe hyperkalemia, and low cortisol is much more characteristic of adrenal insufficiency than typical inborn errors of metabolism.\n\nConsidering the clinical presentation and laboratory findings, 21-hydroxylase deficiency CAH is the most likely etiology. Therefore, the most urgent diagnostic test to confirm this specific underlying cause is a serum 17-hydroxyprogesterone level. The rapid confirmation of CAH guides immediate treatment (glucocorticoid and mineralocorticoid replacement) and long-term management, as well as genetic counseling and screening of family members.\n\nThe final answer is $\\boxed{C}$."}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-009", "question": "A 32-year-old woman with a history of systemic sclerosis (limited cutaneous variant, anti-centromere positive) presents to the rheumatology clinic for routine follow-up. She reports excellent control of her Raynaud's phenomenon and stable skin disease. She has no cardiac or renal symptoms. Her vital signs are normal. A screening transthoracic echocardiogram is performed, which reveals normal left and right ventricular size and function, but there is a small to moderate pericardial effusion. Which of the following findings on echocardiogram would be the strongest indicator to initiate specific pharmacologic therapy directed at the effusion?", "options": ["Right atrial diastolic collapse", "Respiratory variation in mitral inflow velocity >25%", "Inferior vena cava plethora with <50% collapse on sniff", "Swinging heart motion", "Left atrial compression during systole"], "answer": "C", "answer_index": 2, "explanation": "In a patient with a chronic, stable effusion (like those common in connective tissue diseases), the strongest echocardiographic sign of hemodynamic compromise (tamponade physiology) is inferior vena cava (IVC) plethora with minimal respiratory collapse (<50%). This indicates elevated right atrial pressure. In chronic effusions, the chambers have had time to adapt, so classic signs like right atrial collapse may be absent or late. Respiratory variation in mitral inflow (>25%) is a sensitive sign but can be seen in other conditions like COPD. Right atrial collapse is an early sign but less specific in chronic settings. Swinging heart is seen with very large effusions but not specific for tamponade. Left atrial compression is rare.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "NOT FOR CLINICAL USE.\nThe question asks to identify the strongest echocardiographic indicator to initiate specific pharmacologic therapy directed at a pericardial effusion in a patient with systemic sclerosis. The options provided relate to the hemodynamic effects of a pericardial effusion, specifically signs of impending or established cardiac tamponade. Pharmacologic therapy in this context would likely be aimed at managing inflammation contributing to the effusion, or improving cardiac function if hemodynamically compromised, especially if pericardiocentesis is considered or performed. The prompt implies the effusion is causing clinically significant issues.\n\nLet's analyze the options as indicators of hemodynamic compromise:\nA. Right atrial diastolic collapse: This is a classic and highly sensitive sign of cardiac tamponade. During diastole, the right atrium normally fills. If the intrapericardial pressure exceeds the right atrial diastolic pressure, the right atrial wall will collapse inward. This is a direct indication of impaired ventricular filling due to external compression by the effusion.\nB. Respiratory variation in mitral inflow velocity >25%: This finding, assessed by Doppler echocardiography, indicates significant pulsus paradoxus or changes in ventricular filling patterns due to increased intrathoracic pressure swings and impaired diastolic filling, which can be seen in both tamponade and constrictive pericarditis. While indicative of impaired filling, it is not as direct a sign of impending tamponade as chamber collapse.\nC. Inferior vena cava plethora with <50% collapse on sniff: An enlarged inferior vena cava (plethora) that does not collapse significantly during inspiration (sniff) indicates elevated right atrial pressure and suggests impaired venous return to the heart, a common finding in cardiac tamponade.\nD. Swinging heart motion: This describes the visual appearance of the heart moving within a large pericardial effusion. It indicates a large effusion but does not directly quantify the hemodynamic compromise as precisely as chamber collapse or pressure changes.\nE. Left atrial compression during systole: Left atrial compression can occur with large effusions. However, the right side of the heart, with its lower filling pressures, is more susceptible to compression and collapse than the left side. Therefore, right-sided findings are typically earlier and more sensitive indicators of tamponade.\n\nAmong the given options, right atrial diastolic collapse (A) is widely considered one of the earliest and most sensitive echocardiographic signs of impending cardiac tamponade. It signifies that the intrapericardial pressure has risen to a level that impedes the filling of the right atrium, which is the chamber with the lowest diastolic pressure. This condition necessitates intervention, which may include pharmacologic therapy if the effusion is inflammatory in nature, or pericardiocentesis if tamponade is severe. While IVC plethora (C) is also a strong indicator, right atrial collapse is often considered a more direct and sensitive sign of critical compression. Therefore, right atrial diastolic collapse is the strongest indicator among the choices to initiate therapy for a hemodynamically significant pericardial effusion.\n\nThe final answer is $\\boxed{A}$."}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-010", "question": "A 16-year-old girl is brought to the ED after collapsing during her high school soccer game. She was pulseless and apneic but received immediate bystander CPR and was defibrillated once with ROSC after 4 minutes. Her initial ECG in the ED shows sinus rhythm with diffuse ST-segment elevation in precordial leads V1-V4 and inferior leads II, III, aVF. Bedside echocardiogram shows severe hypokinesis of the mid to apical left ventricle with hypercontractility of the basal segments. Troponin I is elevated at 15 ng/mL. Which of the following is the most critical next step in management to prevent recurrence?", "options": ["Immediate coronary angiography", "Initiation of an intravenous beta-blocker", "Insertion of a wearable cardioverter-defibrillator", "Initiation of intravenous immunoglobulin (IVIG)", "Administration of intravenous calcium gluconate"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation and echocardiographic findings are classic for Takotsubo (stress) cardiomyopathy, which can rarely present with ventricular fibrillation arrest. The ECG can mimic STEMI. The most critical step to prevent recurrence of malignant arrhythmias in the acute phase is suppression of catecholamine-driven triggered activity with an intravenous beta-blocker. Immediate coronary angiography is often performed to rule out acute coronary syndrome, but the typical regional wall motion abnormality (apical ballooning) and clinical context make it less likely to be the immediate preventive measure for recurrence. ICD implantation is not indicated in the acute phase of a reversible cardiomyopathy. IVIG is for myocarditis. Calcium is for hyperkalemia or calcium channel blocker overdose.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient is a 16-year-old girl who experienced sudden cardiac arrest (SCA) during physical exertion, received CPR and defibrillation, and achieved ROSC. Her ECG shows diffuse ST-segment elevation in precordial and inferior leads, and her echocardiogram reveals severe hypokinesis of the mid to apical left ventricle with hypercontractility of the basal segments. This pattern on echocardiogram is highly characteristic of Takotsubo cardiomyopathy (TCM), also known as stress-induced cardiomyopathy. Elevated troponin I confirms myocardial injury.\n\nTakotsubo cardiomyopathy, although often benign and reversible, can present with serious complications including ventricular arrhythmias and SCA, particularly in the acute phase or when significant left ventricular dysfunction is present. The patient has already experienced SCA, indicating a high risk for recurrent life-threatening arrhythmias.\n\nLet's evaluate the options in the context of preventing recurrence of SCA:\n\nA.  Immediate coronary angiography: This is the gold standard for diagnosing obstructive coronary artery disease (CAD) in cases of suspected acute coronary syndrome (ACS). While ST-segment elevation and elevated troponins often warrant angiography, the echocardiogram findings (apical ballooning with basal hypercontractility) are not typical for a standard MI caused by a single coronary occlusion. In TCM, coronary angiography typically shows no obstructive CAD or only non-obstructive findings. While ruling out obstructive CAD would be part of the workup, it may not be the *most critical immediate* step to prevent recurrent SCA if TCM is strongly suspected.\n\nB.  Initiation of an intravenous beta-blocker: Beta-blockers are beneficial in managing TCM by reducing sympathetic stimulation, which can help prevent arrhythmias and improve recovery. However, they are not an immediate life-saving intervention against an impending malignant arrhythmia in the same way a defibrillator is.\n\nC.  Insertion of a wearable cardioverter-defibrillator (WCD): Given the patient's history of SCA and the echocardiographic findings suggestive of significant transient left ventricular dysfunction (which can predispose to ventricular arrhythmias), the immediate priority is to protect her from another fatal arrhythmic event. A WCD provides external defibrillation capability while the patient's condition is managed and their electrical stability is assessed. This is crucial for preventing recurrent SCA while awaiting definitive treatment or recovery. Guidelines suggest considering ICD therapy in patients with TCM who experience SCA or have significant LV dysfunction. A WCD is an appropriate intermediate step in such cases.\n\nD.  Initiation of intravenous immunoglobulin (IVIG): IVIG is used for certain inflammatory conditions and is not indicated for the management of Takotsubo cardiomyopathy or SCA unless a specific inflammatory cause is identified (e.g., though highly unlikely in this scenario, certain forms of fulminant myocarditis).\n\nE.  Administration of intravenous calcium gluconate: This is used for conditions like hyperkalemia or cardiac toxicity from calcium channel blockers. It is not indicated in this clinical scenario.\n\nConsidering the patient has already experienced SCA and the most concerning immediate risk is recurrence, the WCD provides the most critical protection against this life-threatening event. While investigating the underlying cause is essential, ensuring immediate safety from further arrhythmias is paramount.\n\nThe final answer is $\\boxed{C}$."}]